OGN - CIK 0001821825
The table below shows Organon & Co.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $700.00M | $939.00M | $799.00M | $858.00M | - | - |
| Capital expenditure | $162.00M | $175.00M | $251.00M | $196.00M | $192.00M | $255.00M |
| Investing cash flow | -$390.00M | -$513.00M | -$260.00M | -$420.00M | - | - |
| Dividends paid | $88.00M | $297.00M | $294.00M | $290.00M | $145.00M | $0.00 |
Organon & Co. reported operating cash flow of $700.00M for fiscal year 2025. That is down 25.5% from $939.00M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | -$561.00M | -$368.00M | -$569.00M | -$433.00M | - | - |